M-HIFU inhibits tumor growth, suppresses STAT3 activity and enhances tumor specific immunity in a transplant tumor model of prostate cancer.
M-HIFU inhibits tumor growth, suppresses STAT3 activity and enhances tumor specific immunity in a transplant tumor model of prostate cancer.
复制标题
DOI:
10.1371/journal.pone.0041632
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Zhong P
中科院分区:
文献类型:
--
作者:
Huang X;Yuan F;Liang M;Lo HW;Shinohara ML;Robertson C;Zhong P
In this study, we explored the use of mechanical high intensity focused ultrasound (M-HIFU) as a neo-adjuvant therapy prior to surgical resection of the primary tumor. We also investigated the role of signal transducer and activator of transcription 3 (STAT3) in M-HIFU elicited anti-tumor immune response using a transplant tumor model of prostate cancer. RM-9, a mouse prostate cancer cell line with constitutively activated STAT3, was inoculated subcutaneously in C57BL/6J mice. The tumor-bearing mice (with a maximum tumor diameter of 5∼6 mm) were treated by M-HIFU or sham exposure two days before surgical resection of the primary tumor. Following recovery, if no tumor recurrence was observed in 30 days, tumor rechallenge was performed. The growth of the rechallenged tumor, survival rate and anti-tumor immune response of the animal were evaluated. No tumor recurrence and distant metastasis were observed in both treatment groups employing M-HIFU + surgery and surgery alone. However, compared to surgery alone, M-HIFU combined with surgery were found to significantly inhibit the growth of rechallenged tumors, down-regulate intra-tumoral STAT3 activities, increase cytotoxic T cells in spleens and tumor draining lymph nodes (TDLNs), and improve the host survival. Furthermore, M-HIFU combined with surgery was found to significantly decrease the level of immunosuppression with concomitantly increased number and activities of dendritic cells, compared to surgery alone. Our results demonstrate that M-HIFU can inhibit STAT3 activities, and when combined synergistically with surgery, may provide a novel and promising strategy for the treatment of prostate cancers.
登录
查看更多内容
影响因子:
11.2
作者:
Bai, JR;Sui, JH;Callery, MP
通讯作者:
Callery, MP
影响因子:
5.2
作者:
Kim, Jeong Kyu;Jung, Kwang Hwa;Nam, Suk Woo
通讯作者:
Nam, Suk Woo
影响因子:
4.4
作者:
Pallandre, Jean-Rene;Brillard, Emilie;Borg, Christophe
通讯作者:
Borg, Christophe
影响因子:
3.6
作者:
Selvendiran, Karuppaiyah;Kuppusamy, M. Lakshmi;Kuppusamy, Periannan
通讯作者:
Kuppusamy, Periannan
影响因子:
8
作者:
Martin, SS;Ridgeway, AG;Leder, P
通讯作者:
Leder, P